Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04051684 · ClinicalTrials.gov registry record · Phase 1
Regional TAP Block for Bariatric Patients
A Phase 1 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT04051684 is a Phase 1 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT04051684, a Phase 1 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI \>35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room
Interventions
- DRUG Ropivacaine
- PROCEDURE Transverse abdominal plane block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04051684
The ClinicalTrials.gov registry entry for NCT04051684 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT04051684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04051684 about?
NCT04051684 is a clinical study titled "Regional TAP Block for Bariatric Patients". Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI \>35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room
What is the current status of trial NCT04051684?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2013-04. Estimated completion is 2013-05.
What interventions are being tested in trial NCT04051684?
The interventions under investigation include: Ropivacaine (DRUG), Transverse abdominal plane block (PROCEDURE).
Who is sponsoring clinical trial NCT04051684?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.